ARTICLE | Company News
DFH Pharma, Hetero Group deal
April 8, 2013 7:00 AM UTC
DFH partnered with Hetero to discover and develop second-generation HIV maturation inhibitors to treat all HIV strains. The compounds block maturation of the HIV gag polyprotein. Hetero will contribu...